Skip to main content
OpenTrials

Clinical trial condition

Tumor Virus Infections

Explore clinical trials studying Tumor Virus Infections. Study availability and eligibility vary by location and protocol.

1,486 public trials 253 recruiting studies
Refine in advanced search Browse all conditions

Tumor Virus Infections trial results

Active, Not Recruiting

SELF-CERV Pivotal Study: SELF-Collection for CERVical Cancer Screening

NCT06120205

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +14 more
Locations
  • Birmingham OBGYN / Alabama Clinical Therapeutics Birmingham, Alabama, United States
  • Planned Parenthood Northern California San Francisco, California, United States
  • University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
  • Planned Parenthood Southern New England New Haven, Connecticut, United States
View all 15 locations
View Trial Details
Active, Not Recruiting

Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation

NCT03475212

Conditions
Adenoviridae Infections, Adenovirus Infection, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +12 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California, Los Angeles Los Angeles, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
View all 30 locations
View Trial Details
Active, Not Recruiting

Safety and Immunogenicity of Extended 2-dose Regimens of 9-valent Human Papillomavirus (9vHPV) Vaccine (V503-069)

NCT04708041

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +10 more
Locations
  • Kaiser Permanente Daly City ( Site 0044) Daly City, California, United States
  • Kaiser Permanente Oakland ( Site 0020) Oakland, California, United States
  • Kaiser Permanente Roseville ( Site 0047) Roseville, California, United States
  • Kaiser Permanente Sacramento ( Site 0043) Sacramento, California, United States
View all 30 locations
View Trial Details
Active, Not Recruiting

Efficacy Against Oral Persistent Infection, Immunogenicity and Safety of the 9-valent Human Papillomavirus Vaccine (9vHPV) in Men Aged 20-45 Years (V503-049)

NCT04199689

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +10 more
Locations
  • Valley Clinical Trials Inc. ( Site 0002) Northridge, California, United States
  • Inland Empire Clinical Trials, LLC ( Site 0025) Rialto, California, United States
  • Alta California Medical Group ( Site 0031) Simi Valley, California, United States
  • Encompass Clinical Research ( Site 0028) Spring Valley, California, United States
View all 103 locations
View Trial Details
Active, Not Recruiting

Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers

NCT03212404

Conditions
Adenocarcinoma, Adenoma, Bronchial Neoplasms, +67 more
Locations
  • Research Site Wollongong, New South Wales, Australia
  • Research Site Benowa, Queensland, Australia
  • Research Site Buderim, Queensland, Australia
  • Research Site Greenslopes, Queensland, Australia
View all 48 locations
View Trial Details

Related conditions